The IndieBio program is part of SOSV, which is a US-based, multi-stage venture fund that specializes in deep tech startups focused on human and planetary health. SOSV operates the IndieBio and HAX (hard tech) startup development programs, which provide deeply resourced facilities for our founders, in New York City (IndieBio), Newark, NJ (HAX) and San Francisco (IndieBio). The programs are designed to provide founders intensive, 1:1 help from technical experts and startup mentors in well-equipped facilities develop their products and launch their companies.

$1.5 billion AUM

SOSV has a portfolio of more than 800 companies and $1.5 billion in assets under management. SOSV’s founder and managing partner is the serial founder, investor and philanthropist Sean O’Sullivan. SOSV’s programs are highly selective and applications to new cohorts are open throughout the year.

$150K to $500K Investments

All companies in SOSV programs receive early stage (typically pre-seed) investment from SOSV, anywhere from $150K to $500K (depending on the program), and SOSV continues to invest as successful program alumni progress through series seed, series A and beyond. SOSV in June 2021 announced a $100 million Select Fund in order to support the rapidly growing number of SOSV companies advancing to later stage rounds.

Worldwide Presence

SOSV has offices in Princeton, NJ (HQ), San Francisco, New York City, Cork (Ireland), Newark, NJ, Tokyo, and Shenzhen.